NAD
Actualité publiée le 18/11/2015
Un nouveau test ADN pour la NEUROAXONAL DYSTROPHY ou NAD est actuellement disponible.
Cette maladie est très connue chez le Papillon et ceci depuis de nombreuses années.
La dystrophie neuro-axonale est une maladie due à l'accumulation de substances diverses au sein des neurones, en particulier du cervelet. Cette maladie est retrouvée préférentiellement chez le Berger Allemand, le Chihuahua, le Jack Russell, le Papillon, le Boxer, le Kerry Blue Terrier, le Border Collie et le Rottweiler. Les symptômes apparaissent chez le jeune animal âgé de quelques mois. Les symptômes d'appels sont ceux d'une atteinte du cervelet avec des troubles de l'équilibre, des chutes et des tremblements de la tête lorsque l'animal va manger, boire ou lorsqu'il veut jouer par exemple. Le pronostic est mauvais, car les symptômes s'aggravent relativement rapidement et du fait de l'absence de traitement, les troubles évoluent lentement. Il existe une forme létale d'apparition fœtale chez le Schnauzer Géant qui entraîne notamment la mort peu après la naissance par détresse respiratoire. Le pronostic est dans ce cas très mauvais, mais il existe un test génétique.
Texte officiel:
Dear PCA Members and the Papillon Community,
It is with great joy that I am able to announce that Dr. Giger’s University of Pennsylvania research laboratory PennGen has established a Papillon specific DNA test for neuroaxonal dystrophy (NAD). In Papillons, NAD is a disorder of young puppies that is a rapidly progressing fatal neuropathy characterized by ataxia and tremors. There is no treatment and affected puppies have to be humanely euthanized by a few months of age. This autosomal recessively inherited brain disorder has been around for at least three decades and is widespread. NAD has been documented or is suspected in different parts of the world including United States, Japan, Australia and Europe, but the overall prevalence is not yet known.
It’s been a long and many times, heartbreaking journey where a diagnosis of NAD could only be reached by necropsy/autopsy. Parents and related dogs had to be considered obligate or suspected carriers but now, a DNA test is available to determine if a particular Papillon is an affected, carrier or clear dog. Most importantly, this test will not only identify the clear dogs, but will allow the informed breeding of a carrier to a clear dog. This will permit the preservation of the precious good genes and the broader gene pool within the Papillon breed.
The Papillon Club of America (PCA) has been working closely with Dr. Giger’s team and with owners and breeders to provide samples from affected and related dogs to further characterize NAD. In addition PCA has provided financial support to advance health of Papillons.
Dr. Giger and his PennGen laboratory have been developing and offering genetic tests for many different diseases in different dog and cat breeds over the past two and a half decades. Now, the PCA Genetics Committee is encouraging Papillon breeders to test their breeding Papillons for NAD.
Initially, Dr. Giger will only be able to offer the test for 400 Papillons as he has a smaller research laboratory with limited manpower. It should be noted that the laboratory will not release any specific information of test results of dogs other than to the owner/submitter, but will inform the Papillon breed club of the prevalence of the mutant allele if samples are sent to his laboratory.
The turn around time is 4 weeks from receiving samples. All submissions have to be done online at PennGen website by setting up an account and then submitting samples and required paperwork for each dog. This will be a cheek swab or EDTA blood sample DNA test which is simple and should be accurate. The test will be $100 and payment will be requested by email when results are available (with or without discount). Once payment has been requested, users will be able to pay online using a credit card and view the results.
Dr. Giger’s research could not have been completed without the owners and breeders who sent in samples from affected and related dogs. Those individuals will receive a letter from Andi Meloon, Chairman of PCA Genetic Committee whereby they will be offered a discount by Dr. Giger with the test fee of $75. This letter will have to be submitted to Dr. Giger along with the samples.
Testing will begin over the next few weeks and notice of the startup will be sent by email to the PCA membership, Facebook and also by sharing with Papillon Breed Clubs. The testing guidelines for collection and shipping will be provided in the next weeks. PCA will be setting up a webpage for the results that individuals submit for publication in the same format that is done for the PRA1 results. The PCA Genetics Committee will have a release form to be signed by the owners/breeders for publication of results. We really encourage the release of genetic information of breeding Papillons as we then can perform informed breedings.
The fear of this disease is nearly over assuming the Papillon breeders will embrace this screening test to perform informed breedings between carriers and clear/normals! Publication of carriers and normals will keep this breed’s gene pool healthy; no results will be released without the explicit agreement of the owner of the Papillon. Our courage to post all results will help those kennel clubs who do not accept carrier results for registration. We have to lead the way.
Also, please note that Dr. Giger has agreed to be the Guest Speaker at the 2016 PCA National.
Sincerely,
Andi Meloon
PCA Genetics Chairman
retour
Cette maladie est très connue chez le Papillon et ceci depuis de nombreuses années.
La dystrophie neuro-axonale est une maladie due à l'accumulation de substances diverses au sein des neurones, en particulier du cervelet. Cette maladie est retrouvée préférentiellement chez le Berger Allemand, le Chihuahua, le Jack Russell, le Papillon, le Boxer, le Kerry Blue Terrier, le Border Collie et le Rottweiler. Les symptômes apparaissent chez le jeune animal âgé de quelques mois. Les symptômes d'appels sont ceux d'une atteinte du cervelet avec des troubles de l'équilibre, des chutes et des tremblements de la tête lorsque l'animal va manger, boire ou lorsqu'il veut jouer par exemple. Le pronostic est mauvais, car les symptômes s'aggravent relativement rapidement et du fait de l'absence de traitement, les troubles évoluent lentement. Il existe une forme létale d'apparition fœtale chez le Schnauzer Géant qui entraîne notamment la mort peu après la naissance par détresse respiratoire. Le pronostic est dans ce cas très mauvais, mais il existe un test génétique.
Texte officiel:
Dear PCA Members and the Papillon Community,
It is with great joy that I am able to announce that Dr. Giger’s University of Pennsylvania research laboratory PennGen has established a Papillon specific DNA test for neuroaxonal dystrophy (NAD). In Papillons, NAD is a disorder of young puppies that is a rapidly progressing fatal neuropathy characterized by ataxia and tremors. There is no treatment and affected puppies have to be humanely euthanized by a few months of age. This autosomal recessively inherited brain disorder has been around for at least three decades and is widespread. NAD has been documented or is suspected in different parts of the world including United States, Japan, Australia and Europe, but the overall prevalence is not yet known.
It’s been a long and many times, heartbreaking journey where a diagnosis of NAD could only be reached by necropsy/autopsy. Parents and related dogs had to be considered obligate or suspected carriers but now, a DNA test is available to determine if a particular Papillon is an affected, carrier or clear dog. Most importantly, this test will not only identify the clear dogs, but will allow the informed breeding of a carrier to a clear dog. This will permit the preservation of the precious good genes and the broader gene pool within the Papillon breed.
The Papillon Club of America (PCA) has been working closely with Dr. Giger’s team and with owners and breeders to provide samples from affected and related dogs to further characterize NAD. In addition PCA has provided financial support to advance health of Papillons.
Dr. Giger and his PennGen laboratory have been developing and offering genetic tests for many different diseases in different dog and cat breeds over the past two and a half decades. Now, the PCA Genetics Committee is encouraging Papillon breeders to test their breeding Papillons for NAD.
Initially, Dr. Giger will only be able to offer the test for 400 Papillons as he has a smaller research laboratory with limited manpower. It should be noted that the laboratory will not release any specific information of test results of dogs other than to the owner/submitter, but will inform the Papillon breed club of the prevalence of the mutant allele if samples are sent to his laboratory.
The turn around time is 4 weeks from receiving samples. All submissions have to be done online at PennGen website by setting up an account and then submitting samples and required paperwork for each dog. This will be a cheek swab or EDTA blood sample DNA test which is simple and should be accurate. The test will be $100 and payment will be requested by email when results are available (with or without discount). Once payment has been requested, users will be able to pay online using a credit card and view the results.
Dr. Giger’s research could not have been completed without the owners and breeders who sent in samples from affected and related dogs. Those individuals will receive a letter from Andi Meloon, Chairman of PCA Genetic Committee whereby they will be offered a discount by Dr. Giger with the test fee of $75. This letter will have to be submitted to Dr. Giger along with the samples.
Testing will begin over the next few weeks and notice of the startup will be sent by email to the PCA membership, Facebook and also by sharing with Papillon Breed Clubs. The testing guidelines for collection and shipping will be provided in the next weeks. PCA will be setting up a webpage for the results that individuals submit for publication in the same format that is done for the PRA1 results. The PCA Genetics Committee will have a release form to be signed by the owners/breeders for publication of results. We really encourage the release of genetic information of breeding Papillons as we then can perform informed breedings.
The fear of this disease is nearly over assuming the Papillon breeders will embrace this screening test to perform informed breedings between carriers and clear/normals! Publication of carriers and normals will keep this breed’s gene pool healthy; no results will be released without the explicit agreement of the owner of the Papillon. Our courage to post all results will help those kennel clubs who do not accept carrier results for registration. We have to lead the way.
Also, please note that Dr. Giger has agreed to be the Guest Speaker at the 2016 PCA National.
Sincerely,
Andi Meloon
PCA Genetics Chairman